NeuroSense Therapeutics to Present at Upcoming U.S. and European ALS Conferences

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Netherlands ,Israel ,Massachusetts ,United States ,Fernando Vieira ,Seanm Healey ,Robert Brown ,Sabrina Paganoni ,James Berry ,Ferenc Tracik ,Shiran Zimri ,Therapy Development Institute ,Linkedin ,Twitter ,Prnewswire Neurosense Therapeutics Ltd ,Drug Administration ,Head Of Scientific Program At Neurosense ,Nasdaq ,Neurosense Therapeutics Ltd ,Research Symposium ,European Medicines Agency ,Umass Memorial Medical School ,Company Phase Iib ,Sense Therapeutics ,Scientific Program ,Chief Medical Officer ,Potential Disease Modifying Treatment ,Novel Biomarkers Measuring Mechanism ,Memorial Medical School ,Merit Cudkowicz ,Massachusetts General Hospital ,Orphan Drug Designation ,Neurosense ,